Gao Xin 2880x880px
Back

Xin Gao

As a Branco Weiss Fellow, Xin Gao will study the rules governing the development of T cells, a type of immune cell that eliminates infected and cancerous cells. Understanding these basic rules will inform the development of new T cell-based vaccines and immunotherapies against chronic infections and cancers.

Background

Nationality
China

Academic Career

  • Postdoctoral Research Fellow, Australian National University, Australia, 2023–present
  • PhD in Immunology, Australian National University, Australia, 2019–2023
  • BSc in Biological Sciences, Wuhan University, China, 2012–2016

Major Awards

  • International Union of Immunological Societies (IUIS) Rising Star, 2025
  • Runner-up for the Australian and New Zealand Society for Immunology (ASI) New Investigator Award, 2024

Research

Branco Weiss Fellow Since
2025

Research Category
Immunology, immunotherapy

Research Location
Biomedicine Discovery Institute, Monash University, Australia

Background

Mammals rely on T cells, a critical component of adaptive immunity, to defend against a wide range of pathogens. Proper T cell development is essential for maintaining health, while dysfunction can increase susceptibility to infections and cancers. Our understanding of T cell development has largely come from studies conducted under homeostatic conditions, whereas the impact of persistent immune challenges such as chronic infections and cancers on T cell development remains elusive.

Details of Research

The central process of T cell development in the thymus involves the formation of random T cell receptors (TCRs) followed by a rigorous selection process known as thymic selection. Only approximately 1–3 % of developing T cells can successfully survive this selection to enter the peripheral circulation. Dr. Gao’s research will investigate the basic principles underlying thymic selection in healthy conditions and examine how chronic infections and malignancies may modify these selective processes. Understanding the rules governing these selection processes could potentially reveal new therapeutic strategies for treating chronic infectious diseases and cancers.